Related Experiment Video
Updated: Jul 7, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Cardiac perforation and tamponade 3 months after transcatheter PFO closure by STARFlex device: A case report
Pascal Motreff1, Claire Dauphin, Géraud Souteyrand
1CHU Clermont-Ferrand, Service de Cardiologie, Hôpital Gabriel Montpied, 63003 Clermont-Ferrand, France. pmotreff@chu-clermontferrand.fr
Abstract:
Percutaneous Patent Foramen Ovale (PFO) closure after paradoxical embolism has become established as a safe, effective and validated procedure. The use of dedicated devices by experienced operators allows for low complication rates and good clinical results in the prevention of paradoxical embolism recurrence. This has led to a widespread use of the technique. However, late complications have been reported after the implantation of different types of devices. We report the first case of cardiac tamponade due to atrial wall erosion, which occurred three months after the implantation of a STARflex device (Nitinol Medical Technologies, Boston, Massachusetts, USA) in a 57 year-old-patient Transoesophageal echocardiographic images and surgical views of the perforation related to the device are presented. This report describes treatment of a late complication that arose following implantation of a STARflex device.
Related Concept Videos
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus.
Pericarditis III: Medical Management
Aneurysm III: Interprofessional Care

